APA

Thürlimann B., Paridaens R., Serin D., Bonneterre J., Roché H., Murray R., di Salle E., Lanzalone S., Zurlo M. G. & Piscitelli G. (19980219). Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group. : European journal of cancer (Oxford, England : 1990).

Chicago

Thürlimann B, Paridaens R, Serin D, Bonneterre J, Roché H, Murray R, di Salle E, Lanzalone S, Zurlo M G and Piscitelli G. 19980219. Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group. : European journal of cancer (Oxford, England : 1990).

Harvard

Thürlimann B., Paridaens R., Serin D., Bonneterre J., Roché H., Murray R., di Salle E., Lanzalone S., Zurlo M. G. and Piscitelli G. (19980219). Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group. : European journal of cancer (Oxford, England : 1990).

MLA

Thürlimann B, Paridaens R, Serin D, Bonneterre J, Roché H, Murray R, di Salle E, Lanzalone S, Zurlo M G and Piscitelli G. Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group. : European journal of cancer (Oxford, England : 1990). 19980219.